Coccidioides Antibody, IgG and IgM

Overview

  • EPIC Code:
  • IMO4183
  • Soft Test Code:
  • COCCI
  • Send Out Test Code:
  • 325
Alternate Names
  • COCCIDIOIDES AB IGG IGM EIA
  • Coccidioides Antibody, IgG & IgM
  • Coccidioides Antibody, IgG and IgM EIA
Clinical Significance

IgM and IgG antibodies to Coccidioides antigen usually appear during the first month of infection, decline over the next 3-6 months but remain detectable for approximately 18-24 months in some cases with self-limited illnesses. Antibodies may persist in patients with chronic pulmonary complications or progressive extrapulmonary (disseminated) coccidioidomycosis. Antibodies may be falsely-negative in some progressive or chronic cases. Follow-up testing maybe considered at weeks 2 – 4 to determine if antibody levels are increasing especially in patients with low positive (10 EU – 20 EU) or intermediate results. Increase in antibody concentration would suggest recent infection. Antibodies may also be detected in healthy subjects who are asymptomatic as a result of sub-clinical infection within the last 18 – 36 months.


Specimen Collection & Preparation

Specimen Requirements

1.0 mL Serum from a SST Gold Top Tube


Alternate Specimen

CSF: Sterile transport tube

1.0 mL Serum from a Red Top Tube in a Plastic Vial


TransportAndStorage

14 days Refrigerated
14 days Frozen


Collection Instructions

Allow blood to clot for 30 minutes, then centrifuge. 
Pipette serum into a plastic screw cap via


Minimum Volume

0.5 mL Serum


Neonatal Volumne

Clinical Interpretation

Reference Range:

Negative 

Negative: <1.0 EU

Positive:  > 1.0 EU

 


Test Comments:

Limitations: 
 8% cross reactivity with Blastomyosis
36% cross reactivity with Histoplasmosis


Methodology:
  • Semi-Quantitative Indirect Enzyme Immunoassay (EIA)

Clinical Significance

IgM and IgG antibodies to Coccidioides antigen usually appear during the first month of infection, decline over the next 3-6 months but remain detectable for approximately 18-24 months in some cases with self-limited illnesses. Antibodies may persist in patients with chronic pulmonary complications or progressive extrapulmonary (disseminated) coccidioidomycosis. Antibodies may be falsely-negative in some progressive or chronic cases. Follow-up testing maybe considered at weeks 2 – 4 to determine if antibody levels are increasing especially in patients with low positive (10 EU – 20 EU) or intermediate results. Increase in antibody concentration would suggest recent infection. Antibodies may also be detected in healthy subjects who are asymptomatic as a result of sub-clinical infection within the last 18 – 36 months.


Documentation

Cross-reactions occur with Aspergillus spp., Histoplasma capsulatum, Parcocidioides brasiliensis, and Talaromyces mameffei.


Production Schedule

Sites Performed
  • MiraVista
Days Performed
Monday
Wednesday
Thursday
Friday
Departments
  • Sendouts - Clinical
Turn Around Time

1 to 2 days


Coding & Compliance

CDM

00913912; 00913899


CPT Coding

86635 x 2